Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
28.32
+0.87 (3.17%)
At close: Feb 24, 2026, 4:00 PM EST
28.32
0.00 (0.00%)
After-hours: Feb 24, 2026, 4:20 PM EST
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.68 billion as of February 24, 2026. Its market cap has increased by 53.09% in one year.
Market Cap
1.68B
Enterprise Value
1.20B
1-Year Change
53.09%
Ranking
Category
Stock Price
$28.32
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.68B, an increase of 72.55%. That is a compound annual growth rate of 19.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 1.63B | 78.25% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innoviva | 1.72B |
| Definium Therapeutics | 1.70B |
| Veradermics | 1.69B |
| Sionna Therapeutics | 1.68B |
| Oruka Therapeutics | 1.67B |
| Celldex Therapeutics | 1.67B |
| Nurix Therapeutics | 1.66B |
| Immunocore Holdings | 1.66B |